Pharmacological services provide a vast array of services to the research industry that are beneficial to companies of all sizes, from biotechnology start-ups to virtual r&d groups to the largest multinational companies. these potential life-changing ideas require funding regulatory navigation and significant amount of infrastructure to go from concept to real world application. offer an array of disease models including microbial infectious disease diet-induced obesity diabetes patient-derived xenografts arthritis lps-induced cytokine production rare genetic diseases